0001127602-24-009544.txt : 20240311 0001127602-24-009544.hdr.sgml : 20240311 20240311211124 ACCESSION NUMBER: 0001127602-24-009544 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240310 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Day Daniel Patrick CENTRAL INDEX KEY: 0001638643 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 24740019 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-10 0000882095 GILEAD SCIENCES, INC. GILD 0001638643 O'Day Daniel Patrick 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 Chairman & CEO 0 Common Stock 2024-03-10 4 M 0 10800 A 479489 D Common Stock 2024-03-10 4 M 0 19140 A 498629 D Common Stock 2024-03-10 4 F 0 13782 75.12 D 484847 D Restricted Stock Unit 2024-03-10 4 M 0 10800 D Common Stock 10800 100092 D Restricted Stock Unit 2024-03-10 4 M 0 19140 D Common Stock 19140 80952 D Non-qualified Stock Option (Right to Buy) 75.12 2024-03-10 4 A 0 279130 0 A 2034-03-10 Common Stock 279130 279130 D Restricted Stock Unit 2024-03-10 4 A 0 54910 A Common Stock 54910 135862 D Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. The options have a four-year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. /s/ Amy Kim by Power of Attorney for Daniel O'Day 2024-03-11